Listed
Inventurus Knowledge Solutions Limited IPO
Inventurus Knowledge Solutions Limited (IKS) is a leading healthcare revenue cycle management (RCM) company offering technology-driven financial and administrative solutions to healthcare providers. The company launched its ₹2,497.92 crore IPO in December 2024, with a price band of ₹1,265 - ₹1,329 per share. The IPO was oversubscribed 52.68 times and listed at a 43% premium on NSE at ₹1,900. IKS continues to expand its global presence, leveraging AI and automation to enhance healthcare financial operations.
Min Investment
₹14,619
Lot Size
11 Shares
Price Range
₹1,265.0 - 1,329.0
Issue Size (₹ Cr.)
₹2,497.92 Cr
IPO Type
Mainboard
Key Metrics
Face Value
₹ 1 per share
GMP
Subscription
52.68x
EPS
₹ 24.31
P/E Ratio
54.66 x
RoNW
32%
ROE
37.63%.
Debt to Equity (₹ Cr.)
0.68
Timeline
IPO Opened12/12/2024Thursday
IPO Closed16/12/2024Monday
Allotted17/12/2024Tuesday
Refunded18/12/2024Wednesday
Listed19/12/2024Thursday
Strengths
- Strong Financial Performance: Consistently high ROE (37.63%) and growing revenues indicate profitability and operational efficiency.
- Moderate Debt Levels: With a Debt-to-Equity ratio of 0.68, the company maintains a balanced capital structure compared to industry peers.
- Global Presence & Client Base: Serves leading healthcare providers worldwide, ensuring stable revenue and long-term contracts.
- Technology-Driven Operations: Leverages AI and automation to enhance healthcare revenue cycle management, improving efficiency.
Weaknesses
- High Debt Levels: With a Debt-to-Equity ratio of 0.68, the company has higher leverage compared to industry peers, increasing financial risk.
- Client Concentration Risk: A significant portion of revenue comes from a few large healthcare clients, making the business vulnerable to contract losses.
- Regulatory Challenges: Operating in the healthcare sector, the company must comply with strict regulations, which could impact operations and profitability.
- Operational Costs: High investments in technology and skilled workforce increase expenses, potentially affecting profit margins.
Financials
| Period Ended | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets (₹Cr) | 2,790.52 | 3,027.52 | 988.31 | 787.52 |
| Revenue (₹Cr) | 1,294.61 | 1,857.94 | 1,060.16 | 784.47 |
| Profit After Tax (₹Cr) | 208.58 | 370.49 | 305.23 | 232.97 |
| Net Worth (₹Cr) | 1,377.11 | 1,157.86 | 828.64 | 647.07 |
| Reserves and Surplus (₹Cr) | 1,360.17 | 1,140.94 | 811.80 | 630.26 |
| Total Borrowing (₹Cr) | 828.63 | 1,193.42 |
Subscription Details
IPO Bidding Live Updates from BSE, NSE
| Day | # of Share Offered | Number of Lots Offered | 12th Dec 2024 19:04 | 13th Dec 2024 19:04 | 16th Dec 2024 18:17 |
|---|---|---|---|---|---|
| QIB | 56,19,154 | 510832 | 1.54x | 1.89x | 80.64x |
| NII | 28,09,576 | 255416 | 0.79x | 3.13x | 23.25x |
| S-NII | 9,36,525 | 85139 | 0.94x | 3.36x | 19.77x |
| B-NII | 18,73,051 | 170277 | 0.72x | 3.02x | 24.99x |
| RII | 18,73,050 | 170277 | 1.70x | 4.26x | 14.55x |
| Total | 1,03,66,780 | 942435 | 1.36x | 2.66x | 52.68x |
IPO Bidding Live Number of Shares by Category
| Category | Number of Shares offered | Number of Shares Bid | Bid Amount(Rs Cr) | ||
|---|---|---|---|---|---|
| QIB | 56,19,154 | 45,31,55,846 | 60,224.41 | ||
| NII | 28,09,576 | 6,53,31,398 | 8,682.54 | ||
| Small NII | 9,36,525 | 1,85,16,520 | 2,460.85 | ||
| Big NII | 18,73,051 | 4,68,14,878 | 6,221.70 | ||
| RII | 18,73,050 | 2,72,56,603 | 3,622.40 | ||
| Total | 1,03,66,780 | 54,60,81,734 | 72,574.26 |
Company Details
- Building No. 5 & 6, Unit No. 801, 8th Floor, Mindspace SEZ, Thane Belapur Road, Airoli, Navi Mumbai, Thane, 400708
+91 22 3964 3205
- company.secretary@ikshealth.com
- N/A
Registrar Details
- C-101, 1st Floor, 247 Park, L.B.S. Marg, Vikhroli (West), Mumbai - 400083, Maharashtra, India
+91-22-4918 6270
- ikshealth.ipo@linkintime.co.in
- https://linkintime.co.in/Initial_Offer/public-issues.html
